Phase II and Coagulation Study of rhuMAb-VEGF With or Without Docetaxel in Patients With Previously Treated Metastatic Pancreatic Adenocarcinoma.
Phase of Trial: Phase II
Latest Information Update: 18 Jun 2013
At a glance
- Drugs Bevacizumab; Docetaxel
- Indications Pancreatic cancer
- Focus Biomarker; Therapeutic Use
- 07 May 2010 Results published in American Journal of Clinical Oncology.
- 16 Feb 2010 Actual end date changed from 1 Nov 2008 to 1 Apr 2009 as reported by ClinicalTrials.gov.
- 10 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History